New Horizon Health (FRA:6YZ) Asset Turnover: 0.26 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6YZ New Horizon Health Ltd FRA:6YZ
35 GF Score
Price €1.62
View Full Analysis

What is New Horizon Health Asset Turnover?

New Horizon Health FRA:6YZ 35 Asset Turnover is 0.26 as of Jun. 2023. GuruFocus rates FRA:6YZ with a GF Score™ of 35/100.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. New Horizon Health's Revenue for the six months ended in Jun. 2023 was €106.0 Mil. New Horizon Health's Total Assets for the quarter that ended in Jun. 2023 was €411.2 Mil. Therefore, New Horizon Health's Asset Turnover for the quarter that ended in Jun. 2023 was 0.26.

Asset Turnover is linked to ROE % through Du Pont Formula. New Horizon Health's annualized ROE % for the quarter that ended in Jun. 2023 was 9.64%. It is also linked to ROA % through Du Pont Formula. New Horizon Health's annualized ROA % for the quarter that ended in Jun. 2023 was 7.88%.


New Horizon Health  (FRA:6YZ) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

New Horizon Health's annulized ROE % for the quarter that ended in Jun. 2023 is

ROE %**(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=32.39/336.059
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(32.39 / 212.062)*(212.062 / 411.181)*(411.181/ 336.059)
=Net Margin %*Asset Turnover*Equity Multiplier
=15.27 %*0.5157*1.2235
=ROA %*Equity Multiplier
=7.88 %*1.2235
=9.64 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) net income data. The Revenue data used here is two times the semi-annual (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

New Horizon Health's annulized ROA % for the quarter that ended in Jun. 2023 is

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=32.39/411.181
=(Net Income / Revenue)*(Revenue / Total Assets)
=(32.39 / 212.062)*(212.062 / 411.181)
=Net Margin %*Asset Turnover
=15.27 %*0.5157
=7.88 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) net income data. The Revenue data used here is two times the semi-annual (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


New Horizon Health Asset Turnover Related Terms


New Horizon Health Asset Turnover Historical Data

* Premium members only.

The historical data trend for New Horizon Health's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health Asset Turnover Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Asset Turnover
0.06 0.14 0.10 0.14 0.31

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Asset Turnover Get a 7-Day Free Trial Premium Member Only 0.03 0.07 0.10 0.22 0.26

FRA:6YZ vs ABT, SYK, MDT: Asset Turnover Comparison

For the Medical Devices subindustry, New Horizon Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Asset Turnover distribution charts can be found below:

* The bar in red indicates where New Horizon Health's Asset Turnover falls into.


FRA:6YZ
35GF Score
New Horizon Health Ltd FRA:6YZ
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

New Horizon Health's Asset Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=103.579/( (327.065+348.643)/ 2 )
=103.579/337.854
=0.31

New Horizon Health's Asset Turnover for the quarter that ended in Jun. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Jun. 2023 ))/ count )
=106.031/( (348.643+473.719)/ 2 )
=106.031/411.181
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.26 mean?
New Horizon Health (FRA:6YZ) has a Asset Turnover of 0.26 as of Jun. 2023. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on New Horizon Health and its competitors.
Is New Horizon Health's Asset Turnover too high?
New Horizon Health's current Asset Turnover is 0.26. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's Asset Turnover compare to ABT and SYK?
New Horizon Health's Asset Turnover of 0.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on New Horizon Health and its competitors. New Horizon Health's current Asset Turnover is 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (FRA:6YZ) has a current Asset Turnover of 0.26. The current Asset Turnover is 0.26. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For New Horizon Health (FRA:6YZ), the current Asset Turnover is 0.26 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for FRA:6YZ

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.62
Price